On GLP-1, power declined more than weight
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), widely prescribed for type 2 diabetes and obesity, have been proposed to modulate testosterone levels
Thyroid function tests may be appropriate if there are clinical features suggesting hypothyroidism, which can develop postnatally and contribute to weight retention
Similarly, GPX4 activators and indirect inducers such as icariin or vitamin derivatives demonstrate antioxidant and chondroprotective effects in preclinical studies (153, 156)
Coverage for weight loss care through Anthem Blue Cross Blue Shield plans in Michigan depends on your employers benefit contract, your plans formulary, and whether FDA-approved obesity medications are included
Transitioning off the combination How you end the combination protocol matters as much as how you start it